PUNE, India, January 3, 2018 /PRNewswire/ -- According to a new market research report "Biosimulation Market by Product (Software, Molecular Simulation, In House, Contract Services), Application (Clinical Trials, PKPD, ADME), Delivery (Subscription, Ownership), End User (Biotech,...
from PR Newswire: //www.prnewswire.co.uk/news-releases/biosimulation-market-worth-288-billion-usd-by-2022-667859253.html
No comments:
Post a Comment